Management of hormone-refractory disease.
Hennequin
C
C
Department of Oncology and Radiation Oncology, Hôpital Saint-Louis, Paris, France. christophe.hennequin@sls.ap-hop-paris.fr
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal